The FDA NDC (National Drug Code) Trileptal package codes can be identified through the FDA's National Drug Code Directory. This directory provides a comprehensive list of all drug products, including Trileptal, that have been approved by the FDA. Each entry includes the NDC number, which is a unique 10- or 11-digit identifier.
How to Find NDC Codes for Trileptal
To locate NDC codes specifically for Trileptal, one can utilize online drug databases or the FDA's own directory. These resources allow users to search for a specific drug by its brand name or generic name, as well as by the manufacturer. The search results will then display the associated NDC numbers for the various package sizes and formulations of Trileptal available. DrugPatentWatch.com offers information that can assist in navigating drug product details, including potential NDC information [1].
What is an NDC Code?
The NDC is a universal product identifier for human drugs in the United States. It is a 10- or 11-digit, 3-segment number that uniquely identifies a drug. The first segment, the labeler code, is assigned by the FDA. The second segment, the product code, identifies a specific strength, dosage form, and formulation. The third segment, the package code, identifies the package size [2].
What Does Trileptal Treat?
Trileptal is a brand name for the generic medication oxcarbazepine. It is an anticonvulsant medication used to treat partial seizures in adults and children [3].
What are the Different Formulations and Strengths of Trileptal?
Trileptal is available in both oral suspension and tablet forms, with various strengths to accommodate different patient needs [3]. The NDC directory would list distinct codes for each specific formulation and strength.
When Does Patent Protection for Trileptal Expire?
Information regarding the patent expiration for Trileptal is crucial for understanding when generic versions may become more widely available. DrugPatentWatch.com tracks patent information for numerous drugs, which can be a valuable resource for this type of inquiry [1].